Most Recent
Funder was ‘moving force’ behind ‘doomed’ Octaviar class action, court told
The Public Trustee of Queensland asked a court Wednesday for indemnity costs from a global litigation funder its says was the "real moving force" behind a dismissed investor class action it called a "nakedly speculative venture".
Rinehart family feud turns on a word, High Court hears
The bitter dispute between Gina Rinehart and two of her children over billions of dollars in iron ore mining assets may come down to how the High Court interprets a single word in an arbitration clause of agreements signed by the warring family members.
Kraft can bring new claims against Bega mid-trial
The long, complex battle over who owns the rights to the Kraft peanut butter trade dress just promised to get longer, with Kraft winning approval to bring fresh allegations against Bega mid-trial.
Adani beats native title challenge to Queensland coal mine
A group of Indigenous Australians has failed to block Adani Mining's $16 billion development of the proposed Carmichael coal mine in central Queensland, with a judge dismissing the claims as "void of merit".
Sanofi launches patent case over Alphapharm injector pen
Global pharmaceutical giant Sanofi-Aventis has launched patent infringement proceedings against generic drug maker Alphapharm seeking "urgent interlocutory relief" to prevent a generic injector pen from being listed on the market.
Securency must pay $64M after ‘shabby fraud’ on businessman
Plastic banknote company Securency has been ordered to pay more than $64 million after it tricked its agent in Nigeria into signing away his commission in what the Federal Court called a "shabby fraud".
Appco can’t put brakes on ‘sham contracting’ class action
Fundraising company Appco Group Australia has failed in its bid to put a massive sham contracting class action in the Federal Court on hold while it fights a ruling that let the case continue as a representative proceeding.
Parties in AMS pelvic mesh class action promise streamlined approach
Lawyers on both sides of the class action against American Medical Services over pelvic mesh implants have taken steps to ensure the case proceeds with greater efficiency than the pelvic mesh class action against Johnson & Johnson, which went to an 89-day trial five years after that case was filed.
Judge overlooked crucial evidence in Nurofen case, Full Court hears
A Federal Court judge skipped vital witness testimony when he ruled Reckitt Benckiser misled consumers about the effectiveness of its Nurofen painkiller, the pharmaceutical company told the Full Federal Court Monday.
Viterra points finger at ex-employees in trial over $420M Joe White sale
Viterra is blaming several former employees for representations made about malt quality in the lead-up to the $420 million sale of its Joe White business to Cargill Australia in 2013.